Medizinische Universität Graz - Research portal

Navigation/Search

• Researchers.
• Institutions.
• Projects.
• Publications.
• Partners.
• Sponsors.
• Equipment.
• Knowhow.
• Fields of Research.

"Faces" of the day:

Katharina Jandl

Nina Höller

Nariae Baik-Schneditz

Ellen Heitzer

Marianne Brodmann

Ewald Kolesnik

Bernhard Schwaberger

Maximilian Seles

Gabor Toth-Gayor

Lukas Peter Mileder

Niels Hammer

Christian Josef Hill

Christian Viertler

Philipp Klaritsch

Daniel Scherr

Harald Köfeler

Gerhard Pichler

Roland Malli

Michael Fuchsjäger

Gernot Plank

Peter Fickert

Richard Zigeuner

Peter Holzer

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Płudowski, P; Kos-Kudła, B; Walczak, M; Fal, A; Zozulińska-Ziółkiewicz, D; Sieroszewski, P; Peregud-Pogorzelski, J; Lauterbach, R; Targowski, T; Lewiński, A; Spaczyński, R; Wielgoś, M; Pinkas, J; Jackowska, T; Helwich, E; Mazur, A; Ruchała, M; Zygmunt, A; Szalecki, M; Bossowski, A; Czech-Kowalska, J; Wójcik, M; Pyrżak, B; Żmijewski, MA; Abramowicz, P; Konstantynowicz, J; Marcinowska-Suchowierska, E; Bleizgys, A; Karras, SN; Grant, WB; Carlberg, C; Pilz, S; Holick, MF; Misiorowski, W.
Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland.
Nutrients. 2023; 15(3): Doi: 10.3390/nu15030695 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz

Pilz Stefan

Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:

Introduction: All epidemiological studies suggest that vitamin D deficiency is prevalent among the Polish general population. Since vitamin D deficiency was shown to be among the risk factors for many diseases and for all-cause mortality, concern about this problem led us to update the previous Polish recommendations. Methods: After reviewing the epidemiological evidence, case-control studies and randomized control trials (RCTs), a Polish multidisciplinary group formulated questions on the recommendations for prophylaxis and treatment of vitamin D deficiency both for the general population and for the risk groups of patients. The scientific evidence of pleiotropic effects of vitamin D as well as the results of panelists' voting were reviewed and discussed. Thirty-four authors representing different areas of expertise prepared position statements. The consensus group, representing eight Polish/international medical societies and eight national specialist consultants, prepared the final Polish recommendations. Results: Based on networking discussions, the ranges of total serum 25-hydroxyvitamin D concentration indicating vitamin D deficiency [<20 ng/mL (<50 nmol/L)], suboptimal status [20-30 ng/mL (50-75 nmol/L)], and optimal concentration [30-50 ng/mL (75-125 nmol/L)] were confirmed. Practical guidelines for cholecalciferol (vitamin D₃) as the first choice for prophylaxis and treatment of vitamin D deficiency were developed. Calcifediol dosing as the second choice for preventing and treating vitamin D deficiency was introduced. Conclusions: Improving the vitamin D status of the general population and treatment of risk groups of patients must be again announced as healthcare policy to reduce a risk of spectrum of diseases. This paper offers consensus statements on prophylaxis and treatment strategies for vitamin D deficiency in Poland.

Find related publications in this database (Keywords)

vitamin D deficiency

25-hydroxyvitamin-D

general population guidelines

risk groups

calcifediol

cholecalciferol

© Med Uni Graz • Imprint